Tools for clinical pharmacists to identify medications that can cause drug-induced cognitive impairment: A systematic review

被引:0
|
作者
Stanton, Jacob [1 ]
Gionfriddo, Michael R. [2 ]
Rattinger, Gail B. [3 ]
Fang, Yuan [3 ]
Lussier, Mia E. [4 ]
机构
[1] Binghamton Univ, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA
[2] Duquesne Univ, Sch Pharm, Div Pharmaceut Adm & Social Sci, Pittsburgh, PA USA
[3] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Binghamton, NY USA
[4] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharm Practice, Binghamton, NY 13902 USA
关键词
adverse effects; cognitive dysfunction; potentially inappropriate medications; ANTICHOLINERGIC DRUGS; RISK;
D O I
10.1002/jac5.2049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cognitive impairment affects around 19% of community-dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive-impairing medications through cognitive-focused medication reviews or as part of comprehensive medication management. Multiple tools exist to help pharmacists and other practitioners identify these medications, yet a comprehensive description of these tools has not been undertaken. We searched EBSCO MEDLINE, PubMed, EMBASE, CINAHL, and PsycInfo from inception to August 4, 2023, using search terms relative to medications and cognition. Studies were included if they detailed a tool to assess the cognitive burden of a medication regimen. Abstracts and full texts were screened independently and in duplicate. Any disagreements at the level of full-text screening were resolved by consensus. Eligible studies underwent data extraction by two authors independently and in duplicate using a data extraction form. Our search identified 13 126 articles of which only four tools were initially included. Additionally, we identified seven articles from the reference lists of excluded review articles for a final inclusion count of 11 tools. Articles were published between 2001 and 2017. Nine of 11 tools (82%) were focused solely on anticholinergic medications, while only one tool indicated a clinically relevant cutoff value and alternative medication recommendations. While there are many tools to assess the cognitive burden from medications, many are limited by the development date, focus on anticholinergic medications, or lack clinically useful information. Further research is needed to develop more comprehensive, up-to-date, and readily implementable tools that clinical pharmacists can utilize to assess medication-induced cognitive risks. Such as tool could be applied by pharmacists in many settings to optimize medication use and improve patient outcomes.
引用
收藏
页码:1207 / 1227
页数:21
相关论文
共 50 条
  • [1] Drug-Induced Cognitive Impairment
    Reimers, Arne
    Odin, Per
    Ljung, Hanna
    DRUG SAFETY, 2025, 48 (04) : 339 - 361
  • [2] Drug-induced cognitive impairment in the elderly
    Moore, AR
    O'Keeffe, ST
    DRUGS & AGING, 1999, 15 (01) : 15 - 28
  • [3] Drug-Induced Cognitive Impairment and Dementia
    O. D. Ostroumova
    T. M. Ostroumova
    A. I. Kochetkov
    A. E. Vorobyova
    A. A. Gadzhibekov
    D. A. Sychev
    Neuroscience and Behavioral Physiology, 2024, 54 (6) : 870 - 877
  • [4] Drug-Induced Cognitive Impairment in the Elderly
    Alan R. Moore
    Shaun T. O’Keeffe
    Drugs & Aging, 1999, 15 : 15 - 28
  • [5] CAN PHARMACISTS PREVENT DRUG-INDUCED ILLNESS IN HOSPITALS
    ZELLMER, WA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (05): : 637 - 637
  • [6] Causes and Clinical Presentation of Drug-Induced Dermatomyositis A Systematic Review
    Caravan, Sahar
    Lopez, Christopher M.
    Yeh, Jennifer E.
    JAMA DERMATOLOGY, 2024, 160 (02) : 210 - 217
  • [7] Drug-induced depression: A systematic review to inform clinical practice
    Patten, SB
    Barbui, C
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2004, 73 (04) : 207 - 215
  • [8] Screening Tools Used by Clinical Pharmacists to Identify Elderly Patients at Risk of Drug-Related Problems on Hospital Admission: A Systematic Review
    Brady, Amanda
    Curtis, Chris E.
    Jalal, Zahraa
    PHARMACY, 2020, 8 (02)
  • [9] ANTIVERTIGO MEDICATIONS AND DRUG-INDUCED VERTIGO - A PHARMACOLOGICAL REVIEW
    RASCOL, O
    HAIN, TC
    BREFEL, C
    BENAZET, M
    CLANET, M
    MONTASTRUC, JL
    DRUGS, 1995, 50 (05) : 777 - 791
  • [10] Drug-induced phototoxicity: A systematic review
    Kim, Whan Ben
    Shelley, Amanda J.
    Novice, Karlee
    Joo, Jiyeh
    Lim, Henry W.
    Glassman, Steven J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (06) : 1069 - 1075